1sharetrader1 is essentially right. Until we get some interim...

1sharetrader1 is essentially right. Until we get some interim data on the IIb trials or a positive response from the USFDA on PRR Orphan status application, we wont see any real movement in sp. This has essentially always been the case for PRR. 18-22c would be a reasonable sp for PRR if Cvac gets Orphan status. The real movement will hopefully come with good interim trials data. This treatment has the capacity for so much good across several cancer related applications. In years to come it will be saving the lives of loved ones who previously would have had little or no hope.

Good Luck all

S